Clinical trialNCT06402968RecruitingObservational

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

SponsorZeenat Qureshi Stroke InstituteEnrollment1,018HypertensionIntracerebral HemorrhageStroke

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California
Irvine, California, United States
Sean R. McDougall
Recruiting
Antelope Valley Medical Center
Lancaster, California, United States
Hisham Salahuddin
Recruiting
Stanford Medical Center (stanford Health Care)
Palo Alto, California, United States
Chitra Venkatasubramanian
Recruiting
Cleveland Clinic Martin North Hospital
Stuart, Florida, United States
Marc Babi
Recruiting
University of South Florida
Tampa, Florida, United States
David Z. Rose
Recruiting
Cleveland Clinic Florida
Weston, Florida, United States
Mubashir Pervez
Recruiting
Augusta University-Neuroscience Center
Augusta, Georgia, United States
Ashutosh Pandey
Recruiting
Wellstar Kennestone Regional Medical Center
Marietta, Georgia, United States
Amreen FarooquiChristopher HornMegha PurohitOvais InamullahRaisa Martinez
Recruiting
Community Hospital
Munster, Indiana, United States
Aamir BadruddinFarrukh Chaudhry
Recruiting
Frederick Memorial Hospital
Frederick, Maryland, United States
Shahid Rafiq
Recruiting
University of Michigan Health-West
Wyoming, Michigan, United States
Fazeel Siddiqui
Recruiting
Centracare - St. Cloud Hospital
Saint Cloud, Minnesota, United States
Fareed Suri
Recruiting
University of Missouri
Columbia, Missouri, United States
Adnan Qureshi
Recruiting
Albany Medical Center
Albany, New York, United States
Nabeel HerialPanayiotis Varelas
Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Fernanda Carvalho-Poyraz
Recruiting
Cleveland Clinic Akron General
Akron, Ohio, United States
Catherine Hassett
Recruiting
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Gomes Joao
Recruiting
Promedica Toledo Hospital
Toledo, Ohio, United States
Mouhammad JumaaSyed F. Zaidi
Recruiting
Ut Southwestern Medical Center
Dallas, Texas, United States
Bappaditya RayDaiWai Olson
Recruiting
University of Texas Health Science Center San Antonio
San Antonio, Texas, United States
Ali Seifi
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Alternate IV Antihypertensive RegimenClevidipine →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Jun 2024
Primary completion: 30 Jan 2028
Completion: 30 Jul 2028
Last update posted: 7 Aug 2026
Registered enrollment: 1,018
Registry id: NCT06402968

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.